
E-cigarettes can feel “cleaner” than smoking because there’s no ash or tar smell, but the science behind that smooth puff is more complex.
Most modern devices use nicotine salts, which are less harsh on the throat and allow higher strengths with rapid absorption. Tiny aerosol droplets carry nicotine deep into the lungs, where large surface area speeds uptake and creates a cigarette-like “hit,” even without combustion. (1)
Heat Changes the Chemistry
An e-liquid looks simple on paper—propylene glycol, vegetable glycerin, flavors, and nicotine—but heating changes everything. High power and long drags push temperatures up, forming irritating carbonyls (like aldehydes) and increasing metal particles from coils. (2)
Many flavorings are safe to eat yet little studied for long-term inhalation. Certain profiles (buttery, spicy, burnt-sugar) can be more irritating when heated. In short, the label lists ingredients, not the chemistry created at the coil.
What Does Nicotine Do to the Body?
Nicotine is a stimulant that raises heart rate and blood pressure and can contribute to stiffer arteries over time. Also, it acts as a neurotoxin to the developing brain, altering the formation of synapses—the connections that enable learning, memory, and attention. This interference can lead to long-term cognitive and behavioral impairments, including mood disorders and a permanent lowering of impulse control. (3)
Even “zero-nicotine” routines can reinforce the behavioral loop (hand-to-mouth cues, flavors, social context), priming later nicotine use or relapse.
Research from the Johns Hopkins Bloomberg School of Public Health has found a significant association between vaping and a diagnosis of depression. (4) While the exact cause-and-effect relationship is still being unraveled, it’s clear that nicotine’s powerful influence on the brain’s reward system can create a volatile cycle of dependency and negative emotional states.
While the long-term neurological and psychological effects are alarming, the immediate physical toll is just as critical to understand.

Infographic design by Boris Benko
Weakening Your Body’s Defenses
The damage isn’t just neurological. The aerosol from e-cigarettes, laden with fine and ultrafine particles, can also weaken the immune system in the lungs. (5)
These particles can impair the function of macrophages, the “clean-up crew” cells in our airways that are responsible for clearing out debris, allergens, and pathogens. When these cells aren’t working properly, the lungs become more vulnerable to infections, leaving users at a higher risk for illnesses like bronchitis and pneumonia. (5)
Devices, Safety, and E-waste
Batteries deserve respect: Damaged cells, cheap chargers, or loose devices in a pocket with keys can create real hazards. Single-use vapes also contribute to e-waste (lithium, plastics), an environmental cost most users never see.
If you vape, make sure to at least choose regulated, repairable devices, store batteries safely, and dispose of used hardware at proper collection points.
A Smarter Exit Strategy
If you smoke cigarettes, complete substitution with a regulated vape may reduce exposure to some toxicants, but treat it as a bridge, not a destination. Set a time-boxed quit plan: taper nicotine strength, shorten puff duration, and switch to a neutral flavor as you step down. Pair this with behavioral supports and reducing screen time during craving windows.
If you don’t smoke, the safest choice is not to start.
FAQ
Yes, and it’s an important gap to fill in, since it remains one of the clearest documented dangers of vaping. Between August 2019 and January 2020, the CDC tracked a nationwide outbreak of e-cigarette or vaping product use-associated lung injury (EVALI), with 2,668 hospitalized cases reported, 82% of patients reporting use of THC-containing vaping products and 57% reporting use of nicotine-containing products. By the time the CDC ended formal case reporting in February 2020, the outbreak had caused 2,807 hospitalizations and 68 deaths, with the predominant pattern being healthy young adults vaping illicit, informally sourced THC cartridges. The likely culprit was identified: vitamin E acetate, used to dilute black-market THC oils, is strongly linked to the outbreak and should never be added to any vaping product, though evidence hasn’t fully ruled out other contributing chemicals. Cases have declined sharply and persistently since the September 2019 peak, but new cases continue to be reported by state health departments.
The evidence genuinely supports it being less harmful, though “less harmful” doesn’t mean “harmless.” The largest review of its kind, from King’s College London, found that while vaping is not risk-free, particularly for people who have never smoked, it poses a small fraction of the health risks of smoking in the short to medium term, with levels of tobacco-specific nitrosamines, volatile organic compounds, and other toxicants implicated in smoking-related diseases found at significantly lower levels in vapers than smokers. The often-cited “95% less harmful” figure needs some context though: that estimate from Public Health England is based on limited data and remains debated among scientists, while the Royal College of Physicians uses more conservative language, concluding vaping poses “a small fraction of the risk” rather than putting a precise number on it.
Yes, and this is now backed by some of the strongest evidence available in medicine. The Cochrane Library, widely considered the gold standard for medical evidence review, found high-certainty evidence that people are more likely to stop smoking for at least six months using nicotine e-cigarettes than using nicotine replacement therapies like patches and gum. In concrete terms, e-cigarettes were found to help around 14 smokers per 100 quit long-term, compared to 6 in 100 trying to quit without any stop-smoking aid, a similar success rate to the smoking-cessation medications varenicline and cytisine.
Both are real, documented conditions tied to specific ingredients rather than vaping in general. Popcorn lung, or bronchiolitis obliterans, is caused by inhaling diacetyl, a buttery-flavor chemical that scars the lungs’ tiny air sacs, and Harvard researchers found this chemical present in 39 of 51 e-cigarette brands tested, primarily in buttery, creamy, or custard-style flavors. Lipoid pneumonia is a different mechanism entirely: unlike infectious pneumonia, it develops when oily substances found in e-liquid enter the lungs directly and trigger an inflammatory response, distinct from the classic pathogen-driven illness. Both remain uncommon relative to the number of people vaping, but they illustrate why “the label lists ingredients, not the chemistry created at the coil,” as the article puts it.
It comes down to pH and how that affects comfort at high concentrations. Freebase nicotine, the original vaping formulation, sits at a pH of roughly 8 to 10, making it alkaline, and that alkalinity is what creates the harsh throat sensation at higher strengths, feeling mild at 3mg but harsh at 18mg and above. Nicotine salts solve this by adding benzoic acid, which lowers the pH to around 5 and shifts the nicotine into a different molecular form, allowing manufacturers to pack in much higher concentrations without the harshness, a formulation JUUL popularized starting in 2016. The absorption-speed claim is more contested than marketing suggests, though: while some industry claims state nicotine salts are absorbed more quickly than freebase, at least one nicotine researcher argues there’s no real absorption difference between the two, and that the smoother throat sensation may simply encourage deeper inhales, creating the illusion of faster absorption.
The overall trend is down, but the pattern underneath it is more concerning. According to the FDA’s 2025 National Youth Tobacco Survey, 7.1% of high school students and 2.6% of middle school students reported current e-cigarette use, continuing a decline in overall use seen from 2022 through 2025. But among the teens who do vape, dependence is intensifying: the share of teen vapers who vape every day nearly doubled, rising from about 15% in 2020 to nearly 29% in 2024, with researchers noting these daily users find it harder to quit. Multi-product use is also common: more than 1 in 3 U.S. high school and middle school students who currently use any tobacco product use more than one type, a pattern known as dual use.
The picture has shifted as research has accumulated, from reassuring to more cautious. Earlier analyses were fairly dismissive of the risk: one influential exposure-modeling study concluded that bystander exposure to vaping toxicants is likely orders of magnitude, meaning multiples of 10, lower than what the user themselves experiences, posing no apparent concern. But more recent research complicates that reassurance. Researchers have found that exposure to secondhand e-cigarette aerosol is associated with increased risk of bronchitis symptoms and shortness of breath in young adults, particularly among those who don’t smoke or vape themselves, with the aerosol containing heavy metals and ultrafine particles that can enter bystanders’ lungs. A 2026 study adds a new wrinkle: secondhand vape aerosol that lingers in indoor air was found to contain metal nanoparticles and reactive peroxides that together form radicals capable of damaging lung tissue, a particular concern for people with asthma or COPD.
Not necessarily, especially with modern high-nicotine devices. A study tracking youth across Canada, England, and the U.S. found that symptoms of e-cigarette dependence increased substantially between 2017 and 2022, reaching levels comparable to cigarette dependence among youth who smoke, with pharmacokinetic studies on salt-based devices like JUUL showing nicotine delivery similar to conventional cigarette smoking. Among adults, the picture is similarly close: one study found vapers exhibit similar subjective nicotine dependence to smokers, despite vapers in the study having a heavier cigarette-smoking history that might have predicted higher dependence overall. There is a meaningful exception worth knowing: people who vape but have never smoked cigarettes show measurably lower dependence than dual users of both products, and dependence scales up directly with nicotine concentration, frequency, and duration of use rather than being fixed by the product type itself.
Sources:
- https://www.ecigarettedirect.co.uk/blogs/ashtray-blog/nic-salts-guide
- https://www.nature.com/articles/s41598-024-52317-8
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7334560/
- https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2756260
- https://link.springer.com/article/10.1007/s40429-021-00359-7


